CAMBRIDGE, Mass., June 29, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that it was added to the Russell 2000(r) Index when Russell Investments reconstituted its comprehensive set of U.S. and global equity indexes on June 26, 2009. The Russell 2000, which is a subset of the Russell 3000(r) Index, measures the performance of the small-cap segment of U.S. equities. Membership in the Russell 2000 is reevaluated annually.
